Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Coagulation abnormalities in liver disease.

K Lechner, H Niessner, E Thaler

    Seminars in Thrombosis and Hemostasis
    |January 1, 1977
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Nomogram for predicting survival after first-line anti-PD-1-based immunotherapy in unresectable stage IV melanoma: a multicenter international study.

    ESMO open·2024
    Same author

    Levosimendan in patients with acute myocardial ischaemia undergoing emergency surgical revascularization.

    European journal of anaesthesiology·2007
    Same author

    Traveller's thrombosis 2001.

    VASA. Zeitschrift fur Gefasskrankheiten·2002
    Same author

    Compression stockings prophylaxis of emergent varicose veins in pregnancy: a prospective randomised controlled study.

    Swiss medical weekly·2002
    Same author

    [Is measuring the depth of anesthesia sensible? An overview on the currently available monitoring systems].

    Anasthesiologie, Intensivmedizin, Notfallmedizin, Schmerztherapie : AINS·2001
    Same author

    Target-controlled infusion or manually controlled infusion of propofol in high-risk patients with severely reduced left ventricular function.

    Journal of cardiothoracic and vascular anesthesia·2001
    Same journal

    Bridging the Gap in Laboratory Monitoring of Extended Half-Life Factor VIII and IX: Can Thrombin Generation Assays Overcome Assay Discrepancies?

    Seminars in thrombosis and hemostasis·2026
    Same journal

    External Quality Assessment for Low Molecular Weight Heparin Monitoring in the Australasia/Asia-Pacific Region.

    Seminars in thrombosis and hemostasis·2026
    Same journal

    Human evolution: between hemorrhage and thrombosis.

    Seminars in thrombosis and hemostasis·2026
    Same journal

    Full- vs Reduced-Dose Direct Oral Anticoagulants for Extended Treatment of Cancer-Associated Thrombosis: A Multicenter Retrospective Cohort Study.

    Seminars in thrombosis and hemostasis·2026
    Same journal

    Too Old for PESI?: Risk Stratification of Octogenarians with Pulmonary Embolism in the Emergency Department.

    Seminars in thrombosis and hemostasis·2026
    Same journal

    Acute Management and Bleeding Outcomes in Pediatric Pulmonary Embolism: A Large Single-Center Retrospective Cohort Study.

    Seminars in thrombosis and hemostasis·2026
    See all related articles

    Liver disease impairs protein synthesis, lowering blood clotting factors and antithrombin III. Measuring these coagulation proteins aids liver function tests and prognosis assessment, but has limited use in differential diagnosis.

    Area of Science:

    • Hepatology
    • Clinical Biochemistry
    • Hematology

    Background:

    • Liver disease significantly reduces the liver's protein synthesis capacity.
    • This impairment leads to decreased blood levels of key coagulation proteins, including factors II, V, VII, IX, X, and antithrombin III.

    Purpose of the Study:

    • To evaluate the utility of measuring specific coagulation proteins as indicators of liver function.
    • To assess the role of these protein levels in guiding prognosis for patients with liver disease.

    Main Methods:

    • Assessing the activity or concentration of clotting factors II, V, VII, IX, X, and antithrombin III in blood.
    • Considering other physiological mechanisms that might affect blood protein levels.

    Main Results:

    Related Experiment Videos

    • Decreased levels of these coagulation proteins are a primary consequence of impaired liver synthesis.
    • Measurement of these proteins serves as a valuable liver function test and prognostic guide when confounding factors are managed.

    Conclusions:

    • Coagulation protein assays are useful for assessing liver function and prognosis in liver disease.
    • These assays have limited applicability in the differential diagnosis of liver conditions.